Skip to content

HyCON Labs

+1 (631) 210-5235

info@hyconlabs.com

  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
Home » Article » Page 4

Article

Menu
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
  • Solid State Form Characterization for Drug Development
    Small Molecule Analytical

    Solid State Form Characterization for Drug Development

    Small Molecule Analytical

    Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…

    Read More Solid State Form Characterization for Drug DevelopmentContinue

  • Amorphouas-Solid-Dispersion
    Formulation Technologies

    Amorphous Solid Dispersion

    Formulation Technologies

    Enhancing Drug Solubility: Understanding Amorphous Solid Dispersions In recent years, amorphous solid dispersions (ASDs) have gained significant popularity and proven to be…

    Read More Amorphous Solid DispersionContinue

  • Image showing medicine dosage
    Development & Bioavailability

    PBPK Modelling: Optimizing Controlled Release Dosage Form Development

    Development & Bioavailability

    Creating controlled release drugs, which release medicine at a specific rate or location in the digestive system, can be difficult. Physiologically-based pharmacokinetic…

    Read More PBPK Modelling: Optimizing Controlled Release Dosage Form DevelopmentContinue

  • A patient taking a pill
    Dosage Form Design

    Dose Design for Patients with Dysphagia

    Dosage Form Design

    Drugs will not work in patients who cannot or do not take them. Non- adherence to prescribed medication regimens is a major…

    Read More Dose Design for Patients with DysphagiaContinue

  • Manufacturing

    How to Overcome Challenges for Accelerated Drug Development

    Manufacturing

    “New drugs receiving expedited approval have shorter timelines, which can create unique challenges for development and manufacturing. Joe Dukich, director of operations…

    Read More How to Overcome Challenges for Accelerated Drug DevelopmentContinue

  • Image showing scientist performing experiment
    Softgel Technology

    Technology Selection for Softgels

    Softgel Technology

    The selection of an appropriate technology for a product is a critical decision that influences its commercial success. The process of technology…

    Read More Technology Selection for SoftgelsContinue

  • 3eb46242aad791aefa762d89a01f631aa5c09f1c73c3bae55df33bcaaa769c33caeea5adbc48
    Dosage Form Design

    How to Choose Dosage Technology for Lipid-Based Formulations

    Dosage Form Design

    Lipid-based drug delivery systems are being recognized as an immensely promising and groundbreaking platform for the development of drug products that integrate…

    Read More How to Choose Dosage Technology for Lipid-Based FormulationsContinue

  • Image showing Hycon Tablets
    Development & Bioavailability | Softgel Technology

    Exploring Compatibility Between Lipid-Based Formulations and Shell Materials

    Development & Bioavailability, Softgel Technology

    To ensure the physical and chemical stability of Lipid-Based Formulations (LBFs), it is essential to find a delicate balance between the formulation…

    Read More Exploring Compatibility Between Lipid-Based Formulations and Shell MaterialsContinue

  • Image showing liquid filled capsules
    Dosage Form Design

    Choosing a Lipid Based Formulation

    Dosage Form Design

    LIQUID IN BOTTLE (LIB) The use of Liquid in Bottle (LIB) as a delivery method provides unparalleled flexibility, eliminating the need for…

    Read More Choosing a Lipid Based FormulationContinue

  • image showing Chemical molecule
    Softgel Technology

    Exploring the Promise of Lipids in Drug Delivery

    Softgel Technology

    In-Depth Understanding of LBDDS The pharmaceutical industry’s exploration into lipid-based drug delivery systems (LBDDS) is a growing trend. Thanks to initiatives like…

    Read More Exploring the Promise of Lipids in Drug DeliveryContinue

Page navigation

Previous PagePrevious 1 2 3 4 5 Next PageNext
Image of ISO Certified Organization
Logo of Current Good Manufacturing Practice
Made in USA Logo
Seal of the United States Drug Enforcement Administration
FDA Approved Icon
WHO - GMP Logo
Certified Organization Logo

Contact us today to start your project in 1 week!

Call +1 (631) 210-5235 to hit the ground running

Contact Us
HyCON Labs a premier small molecule CDMO, enabling pharmaceutical partners to slash development, and manufacturing costs and bring speed to market.
Youtube Linkedin
Services
  • Product Development
  • Processing Technologies
  • Clinical Trial Supply
  • Drug Product Manufacturing
  • Solutions by Phase
Explore
  • Dosage Forms
  • Formulation Technologies
  • Resources
  • About Us
  • Our Locations
Get In Touch

Phone No.: +1 631-210-5235

E-Mail ID: info@hyconlabs.com

© 2025 HyCON Labs Solutions. All Rights Reserved.